These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37407313)

  • 1. An innovative strategy for personalised medicine in a CFSPID case that evolved with time.
    Twynam-Perkins J; Fall A; Lefferts JW; Urquhart DS
    Paediatr Respir Rev; 2023 Sep; 47():23-26. PubMed ID: 37407313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.
    Fevola C; Dolce D; Tosco A; Padoan R; Daccò V; Claut L; Schgor T; Sepe A; Timpano S; Fabrizzi B; Piccinini P; Taccetti G; Bonomi P; Terlizzi V
    Eur J Pediatr; 2024 Feb; 183(2):929-938. PubMed ID: 38054992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial assessments.
    Manzoor J; Hughes DA
    Paediatr Respir Rev; 2023 Sep; 47():19-22. PubMed ID: 37365112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implications and management of cystic fibrosis screen positive, inconclusive diagnosis patients.
    Krishnananthan T; Pao C
    Paediatr Respir Rev; 2019 Aug; 31():21-24. PubMed ID: 31153793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
    J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis to CFSPID: Burden of care vs need and rational approach to weaning therapies.
    Andreou SH; Davies JC
    Paediatr Respir Rev; 2023 Sep; 47():27-29. PubMed ID: 37487798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis.
    Castellani C; Simmonds NJ; Barben J; Addy C; Bevan A; Burgel PR; Drevinek P; Gartner S; Gramegna A; Lammertyn E; Landau EEC; Middleton PG; Plant BJ; Smyth AR; van Koningsbruggen-Rietschel S; Girodon E; Kashirskaya N; Munck A; Nährlich L; Raraigh K; Sermet-Gaudelus I; Sommerburg O; Southern KW
    J Cyst Fibros; 2023 Nov; 22(6):963-968. PubMed ID: 37775442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
    Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
    Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results.
    Ginsburg DK; Salinas DB; Cosanella TM; Wee CP; Saeed MM; Keens TG; Gold JI
    J Cyst Fibros; 2023 May; 22(3):420-426. PubMed ID: 36528525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic challenges in CFTR-related metabolic syndrome: Where the guidelines fall short.
    Kallam EF; Kasi AS; Barr E; Linnemann RW; Guglani L
    Paediatr Respir Rev; 2024 Mar; 49():28-33. PubMed ID: 37659865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
    Salinas DB; Ginsburg DK; Wee CP; Saeed MM; Brewington JJ
    Pediatr Pulmonol; 2023 Apr; 58(4):1074-1084. PubMed ID: 36582049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When CFSPID becomes CF.
    Ginsburg D; Wee CP; Reyes MC; Brewington JJ; Salinas DB
    J Cyst Fibros; 2022 Jan; 21(1):e23-e27. PubMed ID: 34756682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.
    Pagin A; Sermet-Gaudelus I; Burgel PR
    Arch Pediatr; 2020 Feb; 27 Suppl 1():eS25-eS29. PubMed ID: 32172933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.
    Gonska T; Keenan K; Au J; Dupuis A; Chilvers MA; Burgess C; Bjornson C; Fairservice L; Brusky J; Kherani T; Jober A; Kosteniuk L; Price A; Itterman J; Morgan L; Mateos-Corral D; Hughes D; Donnelly C; Smith MJ; Iqbal S; Arpin J; Reisman J; Hammel J; van Wylick R; Derynck M; Henderson N; Solomon M; Ratjen F
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
    Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
    J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
    Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on cystic fibrosis : From neonatal screening to causal treatment].
    Sommerburg O; Wielpütz MO
    Radiologie (Heidelb); 2022 Nov; 62(11):981-994. PubMed ID: 36278998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.